Omeros reported $712K in Stock for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Acelrx Pharmaceuticals ACRX:US $ 1.04M 0.07M
Adma Biologics ADMA:US $ 139.15M 14.42M
Alnylam Pharmaceuticals ALNY:US $ 78.52M 44.18M
Biomarin Pharmaceutical BMRN:US $ 786.36M 9.69M
Dynavax Technologies DVAX:US $ 79.04M 17.7M
Gilead Sciences GILD:US $ 2675M 1057M
Heron Therapeutics HRTX:US $ 56.47M 8.09M
Macrogenics MGNX:US $ 4.6M 0.21M
Pacira Pharmaceuticals PCRX:US $ 103.66M 5.11M
Pfizer PFE:US $ 9979M 920M
Sarepta Therapeutics SRPT:US $ 199M 12.78M
United Therapeutics UTHR:US $ 88.2M 5.6M
Vertex Pharmaceuticals VRTX:US $ 338.9M 14.2M